Clinical trials
Active, not recruiting Ovarian Neoplasms trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Tesaro, Inc. | 2 |
| AbbVie | 1 |
| BeiGene | 1 |
| Compugen Ltd | 1 |
| Corcept Therapeutics | 1 |
| Merck Sharp & Dohme LLC | 1 |
| NeoTX Therapeutics Ltd. | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 13 |
| Breast Neoplasms | 3 |
| Fallopian Tube Neoplasms | 3 |
| Endometrial Neoplasms | 2 |
| Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
| Stomach Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.